Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Issues
    • Current
    • Archives
  • About
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Privacy Statement
    • Contact
  • For Authors
    • Submissions
    • Author Guidelines
    • Peer Review Process
  • Indexing & Abstracting
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 18 No. 3 (2025): Vol 18, No 3 (2025): Summer
  4. Editorial

Vol. 18 No. 3 (2025)

August 2025

First, paradigmatic case of AMA-negative Primary bilairy cholangiitis with Rods and Rings autoantibodies: report of future implications

  • Roberto Assandri

Gastroenterology and Hepatology from Bed to Bench, Vol. 18 No. 3 (2025), 26 August 2025
https://doi.org/10.22037/ghfbb.v18i3.3135 Published: 2025-08-26

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Primary biliary cholangitis (PBC) is the most common autoimmune diseases of the liver. Patients with PBC in characterised by typical biliary pattern symptoms and the presence of anti-mitochondrial autoantibodies (AMAs) in more than 90% of patients and around 50% also show antinuclear antibodies (ANAs).

Based on different studies, anti-Sp100 and anti-PML autoantibodies can

be detected in 20–30% of patients with PBC, mostly in AMA-negative PCB. In recent years, autoantibodies (Aab) targeting subcellular structures described as the Rods and Rings (R&R) have been presented as a unique and particular case of Aab generation.

Now we characterized a patient with contemporary presence of Sp100, PML and R&R Aab (AC-23 pattern following ICAP nomenclature) in PBC, without any laboratory evidence of HCV and/or other hepatic virus infection. For our knowledge, this is the first case of AMA-negative PCB with R&R Aab described in the Literature.

Review of the Literature showed that the AC-23 pattern are present not only in HCV-patient in interferon-ribavirin treatment but, also in ALD.

R&R Aab in patients with PCB confirm and reinforce the association of these Aab to ALD.

Keywords:
  • Autoimmune Hepatitis, Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, Ulcerative Colitis, overlap syndrome.
  • PDF

How to Cite

Assandri, R. (2025). First, paradigmatic case of AMA-negative Primary bilairy cholangiitis with Rods and Rings autoantibodies: report of future implications. Gastroenterology and Hepatology from Bed to Bench, 18(3). https://doi.org/10.22037/ghfbb.v18i3.3135
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 2012;12:65–74.

De Liso F, Matinato C, Ronchi M, Maiavacca R. The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis in anti-mitochondrial antibody-negative patients: a literature review. Clin Chem Lab Med 2017;56:25–31.

Bauer A, Habior A, Wieszczy P, Gawel D. Analysis of autoantibodies against promyelocytic leukemia nuclear body components and biochemical parameters in sera of patients with primary biliary cholangitis. Diagnostics 2021;11:587.

Nakamura M. Clinical significance of autoantibodies in primary biliary cirrhosis. Semin Liver Dis 2014;34:334–40.

Zhang Q, Liu Z, Wu S, Duan W, Chen S, Ou X, et al. Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis. Gastroenterol Res Pract 2019;2019:1–12.

Covini G, Carcamo WC, Bredi E, von Mühlen CA, Colombo M, Chan EK. Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis C. Antivir Ther 2012;17:805–11.

Meng J, Yang G, Li S, Luo Y, Bai Y, Deng C, et al. The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: a retrospective study of two centers in China. Front Immunol 2022;13:1007257.

Assandri R. Primary biliary cholangitis with contemporary presence of anti-mitochondrial and anti-rods and rings autoantibodies: literature first case. Gastroenterol Hepatol Bed Bench 2019;12:76–82.

Assandri R, Montanelli A. Acute severe autoimmune hepatitis with anti-rods and rings autoantibodies: literature first evidence. Gastroenterol Hepatol Bed Bench 2021;14:89–94.

Van Hoovels L, Broeders S, Chan EKL, Andrade L, de Melo Cruvinel W, Damoiseaux J, et al. Current laboratory and clinical practices in reporting and interpreting ANA-IIF patterns: results of an international survey. Auto Immun Highlights 2020;11:17.

Inal N, Kurumanastırlı B, Taskınoglu T, Duran AC, Togay A, Sarıgüzel FM, et al. Retrospective evaluation of “rods and rings” pattern detected in ANA-IIF test. Front Immunol 2024;15:1359030.

Bonroy C, Vercammen M, Fierz W, Andrade LEC, Van Hoovels L, Infantino M, et al. Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP. Clin Chem Lab Med 2023;61:1167–98.

Zhang L, Zhai J, Wang L, Huang Z, Hu J, Li L, et al. The value of anti-rods and rings antibodies in Western China population: a retrospective study. Scand J Immunol 2020;91:e1284.

Stinton LM, Myers RP, Coffin CS, Fritzler MJ. Clinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection. BMC Gastroenterol 2013;13:50.

Climent J, Morandeira F, Castellote J, Xiol J, Niubo J, Calatayud L, et al. Clinical correlates of the “rods and rings” ANA pattern. Autoimmunity 2016;49:102–8.

Afsharzadeh F, Bokharaei-Salim F, Esghaei M, Monavari SH, Merat S, Poustchi H, et al. Autoantibodies to cytoplasmic rod and ring particles in serum of patients with chronic hepatitis C virus infection. Hepat Mon 2016;16:e42388.

Keppeke GD, Prado MS, Nunes E, Perazzio SF, Rodrigues SH, Ferraz ML, et al. Differential capacity of therapeutic drugs to induce rods/rings structures in vitro and in vivo and generation of anti-rods/rings autoantibodies. Clin Immunol 2016;173:149–56.

Assandri R, Monari M, Montanelli A. Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome. Gastroenterol Hepatol Bed Bench 2016;9:211–9.

Valaperta S, Alpini C, Bottone MG, Monari M, Assandri R, Montanelli A. Autoanticorpi anti-Golgi: anche l’occhio vuole la sua parte. Recenti Prog Med 2011;102:11–3.

Assandri R, Serana F, Montanelli A. Development of PBC/SSc overlap syndrome in chronic GVHD patient: immunological implications in the presence of mitochondrial, nucleolar and spindle midzone autoantigens. Gastroenterol Hepatol Bed Bench 2017;10:323–31.

Tolassi C, Assandri R. Evaluation strategy of anti-mitochondrial antibodies M2-negative: the role of multiplex rodent tissues and related clinical implications. Gastroenterol Hepatol Bed Bench 2024;17:1.

Ceribelli A, Isailovic N, Gorlino C, Assandri R, Vecellio M, De Santis M, et al. Antigen reactivity and clinical significance of autoantibodies directed against the pyruvate dehydrogenase antigen complex in connective tissue disease. Front Immunol 2022;13:8221.

  • Abstract Viewed: 95 times
  • PDF Downloaded: 44 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

 

GHFBB is an open-access journal and does not charge fees for authors who submit their articles and for readers who access PDF files of published articles.

Powered by OJSPlus